胆固醇代谢与恶性肿瘤

摘要/Abstract

摘要：已有研究证实胆固醇代谢在肿瘤发生、发展过程中发挥着重要的作用，同时也在预测恶性肿瘤预后中显示出重要的应用价值。胆固醇可以通过对恶性肿瘤患者进行恰当的风险分层，来提高肿瘤患者远期的生命质量和生存时间。

师园园，卢宁. 胆固醇代谢与恶性肿瘤[J]. 国际肿瘤学杂志, 2017, 44(7): 522-525.

Shi Yuanyuan, Lu Ning. Cholesterol metabolism and malignant tumors[J]. Journal of International Oncology, 2017, 44(7): 522-525.

［1］ Ma LM, Liang ZR, Zhou KR, et al. 27Hydroxycholesterol increases Myc protein stability via suppressing PP2A, SCP1 and FBW7 transcription in MCF-7 breast cancer cells［J］. Biochem Biophys Res Commun, 2016, 480(3): 328-333. DOI: 10.1016/j.bbrc.2016.10.038. ［2］ Alikhani N, Ferguson RD, Novosyadlyy R, et al. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model［J］. Oncogene, 2013, 32(8): 961-967. DOI: 1038/onc.2012.113. ［3］王瑜敏, 黄海霞, 袁谦. 肺癌患者放疗过程中血脂的动态变化及意义［J］. 江西医学检验, 2015, 23(2): 129-131. ［4］ Chi PD, Liu W, Chen H, et al. Highdensity lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with Creactive protein level in nonsmall cell lung carcinoma［J］. PLoS One, 2014, 9(3): e91080. DOI: 10.1371/journal.pone.0091080. ［5］ Agnoli C, Grioni S, Sieri S, et al. Metabolic syndrome and breast cancer risk: a casecohort study nested in a multicentre italian cohort［J］. PLoS One, 2015, 10(6): e0128891. DOI: 10.1371/journal.pone.0128891. ［6］ Rodrigues Dos Santos C, Fonseca I, Dias S, et al. Plasma level of LDLcholesterol at diagnosis is a predictor factor of breast tumor progression［J］. BMC Cancer, 2014, 14: 132. DOI: 10.1186/1471240714132. ［7］刘业六, 钱海鑫, 秦磊, 等. 血脂相与乳腺癌远处转移的关系［J］. 中华肿瘤杂志, 2012, 34(2): 129131. DOI: 10.3760/cma.j.issn.02533766.2012.02.010. ［8］ Pan B, Ren H, He Y, et al. HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis［J］. Clin Cancer Res, 2012, 18(5): 1246-1256. DOI: 10.1158/10780432.CCR110817. ［9］潘巨龙, 严佳斌, 郑玉萍. 乳腺癌骨转移患者血脂和血浆CA153联检对早期诊断的临床价值［J］. 放射免疫学杂志, 2012, 25(4): 463-465. DOI: 10.3969/j.issn.1008-9810.2012.04.055. ［10］ Ghahremanfard F, Mirmohammadkhani M, Shahnazari B, et al. The valuable role of measuring serum lipid profile in cancer progression［J］. Oman Med J, 2015, 30(5): 353-357. DOI: 10.5001/omj.2015.71. ［11］ Wulaningsih W, Garmo H, Holmberg L, et al. Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study［J］. J Cancer Epidemiol, 2012, 2012: 792034. DOI: 10.1155/2012/792034. ［12］ Tamura T, Inagawa S, Hisakura K, et al. Evaluation of serum highdensity lipoprotein cholesterol levels as a prognostic factor in gastric cancer patient［J］. J Gastroenterol Hepatol, 2012, 27(10): 1635-1640. DOI: 10.1111/j.1440-1746.2012.07189.x. ［13］ Guo E, Chen L, Xie Q, et al. Serum HDLC as a potential biomarker for nodal stages in gastric cancer［J］. Ann Surg Oncol, 2007, 14(9): 2528-2534. DOI: 10.1245/s1043400794010. ［14］ Gorin A, Gabitova L, Astsaturov I. Regulation of cholesterol biosynthesis and cancer signaling［J］. Curt Opin Pharmacol, 2012, 12（6）: 710-716. DOI: 10.1016/j.Coph.2012.06.011. ［15］ Wertheim BC, Smith JW, Fang C, et a1. Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis［J］. Cancer Prey Res (Phila), 2012, 5(2): 197-204. DOI: 10.1158/19406207.CAPR-11-0320. ［16］ Lochhead P, Chan AT. Statins and colorectal cancer［J］. Clin Gastroenterol Hepatol, 2013, 11(2): 109-118. DOI: 10.1016/j.cgh.2012.08.037. ［17］ Liu CS, Hsu HS, Li CI, et al. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population［J］. BMC Gastroenterol, 2010, 10: 51. DOI: 10.1186/1471-230x-10-51. ［18］ Yang MH, Rampal S, Sung J, et al. The association of serum lipids with colorectal adenomas［J］. Am J Gastroenterol, 2013, 108(5): 833-841. DOI: 10.1038/ajg.2013.64. ［19］ Moon H, Ruelcke JE, Choi E, et al. Dietinduced hypereholesterolemia promotes androgenindependent prostate cancer metastasis via IQGAP1 and caveolin1［J］. Oncotarget, 2015, 6(10): 7438-7453. DOI: 10.18632/oncotarget.3476. ［20］ Morote J, Celma A, Planas J, et al. Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness［J］. Int J Mol Sci, 2014, 15(8): 13615-13623. DOI: 10.3390/ijms150813615. ［21］ Van Hemelrijck M, Walldius G, Jungner I, et al. Low levels of apolipoproteina AI and HDL are associated with risk of prostate cancer in the Swedish AMORIS study［J］. Cancer Causes Control, 2011, 22(7): 1011-1019. DOI: 10.1007/s10552011-9774-z. ［22］ Seko Y, Akuta N, Suzuki F, et al. Amino acid substitutions in the hepatitis C virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy［J］. Intervirology, 2013, 56(1): 13-21. DOI: 10.1159/000339993. ［23］ Wolk A, Larsson SC, Johansson JE, et al. Longterm fatty fish consumption and renal cell carcinoma incidence in women［J］. JAMA, 2006, 296(11): 1371-1376. DOI: 10.1001/jama.296.11.1371. ［24］ de Martino M, Leitner CV, Seemann C, et al. Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma(RCC)［J］. BJU Int, 2015, 115(3): 397-404. DOI: 101111/bju.12767. ［25］徐数娜, 张旭辉, 张日. 急性白血病患者血脂、血糖及蛋白检测的临床意义［J］. 中华临床医师杂志:电子版, 2013, 7(9): 4089-4090. DOI: 10.3877/cma.j.issn.1674-0785.2013.09.127. ［26］ Pereira EB, Gemignani T, Sposito AC, et al. Lowdensity lipoprotein cholesterol and radiotherapyinduced carotid atherosclerosis in subjects with head and neck cancer［J］. Radiat Oncol, 2014, 9: 134. DOI: 10.1186/1748-717X-9-134. ［27］ Borena W, Strohmaier S, Lukanova A, et al. Metabolic risk factors and primary liver cancer in a prospective study of 578, 700 adults［J］. Int J Cancer, 2012, 131(1): 193-200. DOI: 10.1002/ijc. 26338. ［28］杨灿. 血清高密度脂蛋白胆固醇水平用于评价肝脏合成功能的价值［J］. 吉林医学, 2016, 37(7): 1773. DOI: 10.3969/j.issn.10040412.2016.07.137.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.

Cholesterol metabolism and malignant tumors

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价